Molecular driver alterations and their clinical relevance in cancer of unknown primary site

Cancer of unknown primary (CUP) is defined as metastatic solid malignancy where no primary tumor is detected despite appropriate staging. About 90% of CUP represent adenocarcinoma or undifferentiated carcinoma. Since therapy regimens are only modestly effective, identification of the molecular lands...

Descripción completa

Detalles Bibliográficos
Autores principales: Löffler, Harald, Pfarr, Nicole, Kriegsmann, Mark, Endris, Volker, Hielscher, Thomas, Lohneis, Philipp, Folprecht, Gunnar, Stenzinger, Albrecht, Dietel, Manfred, Weichert, Wilko, Krämer, Alwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190099/
https://www.ncbi.nlm.nih.gov/pubmed/27322425
http://dx.doi.org/10.18632/oncotarget.10035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190099/
https://www.ncbi.nlm.nih.gov/pubmed/27322425
http://dx.doi.org/10.18632/oncotarget.10035

Ejemplares similares